Table 1.

Scheduled visits and procedures

	Enrollment/baseline	Allocation	Intervention (3 days)			Follow-up
	− D5	D0	D0	D1	D2	Week 6	Week 12
Enrollment
Stool examination	X
Eligibility screen	X
Informed consent/assent		X
Child assent		X
Randomization		X
Intervention
Praziquantel alone			X
Praziquantel plus ACTa			X	X	X
Assessment
Baseline assessment
Body weight and height	X					X	X
Hemoglobin (HemoCue)	X					X	X
Outcome assessment
Stool examination						X	X
Safety assessment
Adverse events	X		X	X	X	X

^aACT includes any of artesunate plus sulfalene-pyrimethamine, artesunate plus amodiaquine, artesunate plus mefloquine, or dihydroartemisinin-piperaquine